Long COVID Trial, Recruiting NCT06928480 Sponsor: Instituto de Investigación Sanitaria Aragón Condition: Long COVID
Back to Long Covid

Long COVID Trial, Recruiting

NCT06928480
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You currently live in the Autonomous Community of Aragon, Spain
  • You are at least 18 years old
  • You can understand and communicate in Spanish
  • You have been diagnosed with Long COVID, meaning you had a confirmed COVID-19 infection and have had ongoing symptoms for more than 12 weeks after getting sick
  • You are experiencing symptoms of depression and/or anxiety, measured at a certain level using specific questionnaires (confirm with trial site)
  • You meet the criteria for an emotional disorder diagnosis (confirm with trial site)
  • You have access to the internet
  • You are willing to sign a consent form agreeing to take part in the study

Who may not be able to join:

  • You had symptoms of depression or anxiety before you got COVID-19
  • You are currently receiving psychological therapy or treatment
  • You have been diagnosed with a serious mental health condition, such as a personality disorder or bipolar disorder
  • You are currently having thoughts of suicide at the time of your assessment
  • If you are taking medication for mental health, you must be able to keep the same dose throughout the study, unless your doctor advises otherwise

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +34 978645390

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Instituto de Investigación Sanitaria Aragón
Registry
ClinicalTrials.gov
Start date
1 May 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

General Depression Severity and Interference Scale (ODSIS; Bentley et al., 2014. Validated in Spanish by Osma et al., 2019); General Severity and Interference Scale for Anxiety (OASIS; Norman et al., 2006. Validated in Spanish by Osma et al., 2019)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov